Hologic to sell $1 billion two-part senior notes in Tuesday drive-by

By Paul A. Harris

Portland, Ore., Jan. 16 – Hologic, Inc. plans to price $1 billion of senior notes in two tranches on Tuesday trailing a late-morning conference call with investors, according to a syndicate source.

The Rule 144A and Regulation S for life deal features an add-on to the 4 3/8% notes due Oct. 15, 2025, callable on Oct. 15, 2020 at 102.188. The original $350 million issue priced at par on Oct. 4, 2017.

The offering also features a tranche of new 10-year notes, callable after five years at par plus 50% of the coupon.

Tranche sizes remain to be determined.

Goldman Sachs & Co. is the left bookrunner. BofA Merrill Lynch, J.P. Morgan Securities LLC, MUFG, Citigroup Global Markets Inc., Wells Fargo Securities LLC and Morgan Stanley & Co. LLC are the joint bookrunners.

HSBC Securities (USA) Inc., DNB NOR Markets Inc. and SMBC Nikko are the senior co-managers. Fifth Third, Scotia Capital, PNC Capital Markets, TD Securities, Mizuho Securities, Citizens Bank, KeyBanc Capital Markets and Janney Montgomery Scott LLC are the co-managers.

The Marlborough, Mass.-based medical technology company plans to use the proceeds to refinance its 5¼% senior notes due 2022.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.